{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:09:16Z","timestamp":1777086556436,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":37,"publisher":"Springer US","isbn-type":[{"value":"9781071618837","type":"print"},{"value":"9781071618844","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1884-4_10","type":"book-chapter","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T16:04:44Z","timestamp":1639670684000},"page":"209-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CRISPR Engineering of Bacteriophage T4 to Design Vaccines Against SARS-CoV-2 and Emerging Pathogens"],"prefix":"10.1007","author":[{"given":"Jingen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeti","family":"Ananthaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venigalla B.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"issue":"8","key":"10_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382(8):727\u2013733","journal-title":"N Engl J Med"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270\u2013273","journal-title":"Nature"},{"issue":"1","key":"10_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"F Li","year":"2016","unstructured":"Li F (2016) Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 3(1):237\u2013261","journal-title":"Annu Rev Virol"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019Kovski","year":"2020","unstructured":"V\u2019Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V (2020) Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 19:155\u2013170","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"10_CR5","doi-asserted-by":"publisher","first-page":"12522","DOI":"10.1021\/acsnano.0c07197","volume":"14","author":"YH Chung","year":"2020","unstructured":"Chung YH, Beiss V, Fiering SN, Steinmetz NF (2020) COVID-19 vaccine frontrunners and their nanotechnology design. ACS Nano 14(10):12522\u201312537","journal-title":"ACS Nano"},{"issue":"8","key":"10_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","volume":"15","author":"MD Shin","year":"2020","unstructured":"Shin MD et al (2020) COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol 15(8):646\u2013655","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"10_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","volume":"5","author":"Y Dong","year":"2020","unstructured":"Dong Y et al (2020) A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther 5(1):237","journal-title":"Signal Transduct Target Ther"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41579-020-00462-y","volume":"19","author":"S Su","year":"2020","unstructured":"Su S, Du L, Jiang S (2020) Learning from the past: development of safe and effective COVID-19 vaccines. Nat Rev Microbiol 19:211\u2013219","journal-title":"Nat Rev Microbiol"},{"issue":"7830","key":"10_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett KS et al (2020) SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586(7830):567\u2013571","journal-title":"Nature"},{"issue":"7830","key":"10_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","volume":"586","author":"J Yang","year":"2020","unstructured":"Yang J et al (2020) A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 586(7830):572\u2013577","journal-title":"Nature"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","volume":"27","author":"KJ Ewer","year":"2020","unstructured":"Ewer KJ et al (2020) T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial. Nat Med 27:270\u2013278","journal-title":"Nat Med"},{"issue":"7830","key":"10_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","volume":"586","author":"F Krammer","year":"2020","unstructured":"Krammer F (2020) SARS-CoV-2 vaccines in development. Nature 586(7830):516\u2013527","journal-title":"Nature"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.addr.2020.12.008","volume":"169","author":"KS Park","year":"2020","unstructured":"Park KS, Sun X, Aikins ME, Moon JJ (2020) Non-viral COVID-19 vaccine delivery systems. Adv Drug Deliv Rev 169:137\u2013151","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","volume":"183","author":"AC Walls","year":"2020","unstructured":"Walls AC et al (2020) Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Cell 183(5):1367\u20131382.e1317","journal-title":"Cell"},{"issue":"4","key":"10_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette A, Crotty S (2021) Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184(4):861\u2013880","journal-title":"Cell"},{"issue":"7851","key":"10_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler C et al (2021) Evolution of antibody immunity to SARS-CoV-2. Nature 591(7851):639\u2013644","journal-title":"Nature"},{"issue":"1","key":"10_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","volume":"12","author":"TK Tan","year":"2021","unstructured":"Tan TK et al (2021) A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nat Commun 12(1):542","journal-title":"Nat Commun"},{"issue":"6","key":"10_CR18","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","volume":"53","author":"X Ma","year":"2020","unstructured":"Ma X et al (2020) Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity 53(6):1315\u20131330.e1319","journal-title":"Immunity"},{"key":"10_CR19","doi-asserted-by":"crossref","unstructured":"Zhu J et al (2021) A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering. Science Advances 7:eabh1547","DOI":"10.1126\/sciadv.abh1547"},{"issue":"4","key":"10_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0022-2836(77)80088-0","volume":"109","author":"T Ishii","year":"1977","unstructured":"Ishii T, Yanagida M (1977) The two dispensable structural proteins (soc and hoc) of the T4 phage capsid; their purification and properties, isolation and characterization of the defective mutants, and their binding with the defective heads in vitro. J Mol Biol 109(4):487\u2013514","journal-title":"J Mol Biol"},{"issue":"16","key":"10_CR21","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1073\/pnas.0400444101","volume":"101","author":"A Fokine","year":"2004","unstructured":"Fokine A et al (2004) Molecular architecture of the prolate head of bacteriophage T4. Proc Natl Acad Sci U S A 101(16):6003\u20136008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"10_CR22","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1128\/JVI.00847-11","volume":"85","author":"A Fokine","year":"2011","unstructured":"Fokine A et al (2011) Structure of the three N-terminal immunoglobulin domains of the highly immunogenic outer capsid protein from a T4-like bacteriophage. J Virol 85(16):8141\u20138148","journal-title":"J Virol"},{"issue":"5","key":"10_CR23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jmb.2007.05.008","volume":"370","author":"Q Li","year":"2007","unstructured":"Li Q, Shivachandra SB, Zhang Z, Rao VB (2007) Assembly of the small outer capsid protein, Soc, on bacteriophage T4: a novel system for high density display of multiple large anthrax toxins and foreign proteins on phage capsid. J Mol Biol 370(5):1006\u20131019","journal-title":"J Mol Biol"},{"issue":"15","key":"10_CR24","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1073\/pnas.1300867110","volume":"110","author":"P Tao","year":"2013","unstructured":"Tao P et al (2013) In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. Proc Natl Acad Sci U S A 110(15):5846\u20135851","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003495","volume":"9","author":"P Tao","year":"2013","unstructured":"Tao P et al (2013) Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines. PLoS Pathog 9(7):e1003495","journal-title":"PLoS Pathog"},{"issue":"7","key":"10_CR26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.vaccine.2006.10.010","volume":"25","author":"SB Shivachandra","year":"2007","unstructured":"Shivachandra SB et al (2007) Multicomponent anthrax toxin display and delivery using bacteriophage T4. Vaccines 25(7):1225\u20131235","journal-title":"Vaccines"},{"issue":"5","key":"10_CR27","doi-asserted-by":"publisher","first-page":"e01926","DOI":"10.1128\/mBio.01926-18","volume":"9","author":"P Tao","year":"2018","unstructured":"Tao P et al (2018) A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague. MBio 9(5):e01926","journal-title":"MBio"},{"issue":"8","key":"10_CR28","doi-asserted-by":"publisher","first-page":"eaax0064","DOI":"10.1126\/sciadv.aax0064","volume":"5","author":"J Zhu","year":"2019","unstructured":"Zhu J et al (2019) A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells. Sci Adv 5(8):eaax0064","journal-title":"Sci Adv"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.addr.2018.06.025","volume":"145","author":"P Tao","year":"2018","unstructured":"Tao P, Zhu J, Mahalingam M, Batra H, Rao VB (2018) Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases. Adv Drug Deliv Rev 145:57\u201372","journal-title":"Adv Drug Deliv Rev"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3389\/fimmu.2017.00687","volume":"8","author":"P Tao","year":"2017","unstructured":"Tao P et al (2017) A bivalent anthrax-plague vaccine that can protect against two tier-1 bioterror pathogens, Bacillus anthracis and Yersinia pestis. Front Immunol 8:687","journal-title":"Front Immunol"},{"issue":"19","key":"10_CR31","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1016\/j.jmb.2019.07.022","volume":"431","author":"M Plattner","year":"2019","unstructured":"Plattner M et al (2019) Structure and function of the branched receptor-binding complex of bacteriophage CBA120. J Mol Biol 431(19):3718\u20133739","journal-title":"J Mol Biol"},{"issue":"10","key":"10_CR32","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1021\/acssynbio.7b00179","volume":"6","author":"P Tao","year":"2017","unstructured":"Tao P, Wu X, Tang WC, Zhu J, Rao V (2017) Engineering of bacteriophage T4 genome using CRISPR-Cas9. ACS Synth Biol 6(10):1952\u20131961","journal-title":"ACS Synth Biol"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"e01630","DOI":"10.1128\/JVI.01630-20","volume":"94","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020) Covalent modifications of bacteriophage genome confer a degree of resistance to bacterial CRISPR systems. J Virol 94:e01630. https:\/\/doi.org\/10.1128\/JVI.01630-20","journal-title":"J Virol"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1021\/acsnano.6b07343","volume":"11","author":"KT Gause","year":"2017","unstructured":"Gause KT et al (2017) Immunological principles guiding the rational design of particles for vaccine delivery. ACS Nano 11:54\u201368","journal-title":"ACS Nano"},{"issue":"12","key":"10_CR35","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41594-020-00536-8","volume":"27","author":"VS Mandala","year":"2020","unstructured":"Mandala VS et al (2020) Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol 27(12):1202\u20131208","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"10_CR36","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nmeth.2681","volume":"10","author":"KM Esvelt","year":"2013","unstructured":"Esvelt KM et al (2013) Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods 10(11):1116\u20131121","journal-title":"Nat Methods"},{"issue":"7","key":"10_CR37","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3573","volume":"10","author":"J Zhu","year":"2020","unstructured":"Zhu J, Tao P, Mahalingam M, Rao VB (2020) Preparation of a bacteriophage T4-based prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells. Bio-protocol 10(7):e3573","journal-title":"Bio-protocol"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1884-4_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T02:11:25Z","timestamp":1662171085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1884-4_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"ISBN":["9781071618837","9781071618844"],"references-count":37,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1884-4_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"17 December 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}